期刊文献+

影响耐碳青霉烯类肺炎克雷伯菌感染患儿死亡的危险因素分析 被引量:1

Analysis on Risk Factors Influencing Death of Children with Carbapenem-resistant Klebsiella Pneumonia Infection
下载PDF
导出
摘要 目的:调查并分析影响耐碳青霉烯类肺炎克雷伯菌感染(CRKP)患儿死亡的危险因素。方法:对2013年3月—2019年3月在我院进行治疗209例CRKP患儿资料予以回顾性分析,依据患儿预后情况将其分为死亡组(n=18)和存活组(n=191),比较两组患儿相关资料,对影响患儿死亡危险因素进行分析。结果:单因素分析结果显示两组患儿在体质量指数,白蛋白水平,住院时间,是否进行侵入性操作,治疗使用抗生素时间,治疗使用抗生素种类,治疗使用糖肽类、头孢类以及碳青霉烯类抗菌药物等因素之间比较差异有统计学意义(P<0.05),多因素Logistic分析结果显示,侵入性操作、治疗使用抗生素时间、抗生素种类以及碳青霉烯类抗菌药物为影响CRKP患儿死亡危险因素(P<0.05),而体质量指数,白蛋白水平,住院时间,治疗使用糖肽类、头孢类抗菌药物不是影响CRKP患儿死亡的危险因素(P>0.05)。结论:CRKP患儿应该加强侵入操作管理,合理把握抗生素使用时间,规范使用抗生素以改善此类患儿的预后。 Objective:To investigate and analyze risk factors influencing death of children with Carbapenem-resistant Klebsiella pneumonia(CRKP)infection.Methods:A retrospective analysis was performed on the data of 209 CRKP children who were treated in the hospital from March 2013 to March 2019.They were included in death group(n=18)and control group(n=191)according to their prognosis.The related data were compared between the two groups.The risk factors influencing their death were analyzed.Results:The results of univariate analysis showed there were significant differences in body mass index,albumin level,hospitalization time,invasive operation,antibiotic usage time,antibiotic usage types,usage of glycopeptides,cephalosporins,carbapenems antibiotics between the two groups(P<0.05).The results of multivariate Logistic analysis showed invasive operation,antibiotic usage time,antibiotic usage types and usage of carbapenem antibiotics were risk factors influencing death of CRKP children(P<0.05)while,body mass index,albumin level,hospitalization time,glycopeptides,cephalosporin antibiotics were not risk factors(P>0.05).Conclusion:CRKP children should strengthen invasive operation management,reasonably grasp antibiotic usage time,and regulate antibiotics usage to improve their prognosis.
作者 涂继军 TU Jijun(The 7th People’s Hospital of Zhengzhou,He’nan Province 450006)
出处 《医学理论与实践》 2020年第5期708-709,712,共3页 The Journal of Medical Theory and Practice
关键词 耐碳青霉烯类 肺炎克雷伯菌感染儿童 死亡 危险因素 Carbapenem-resistant Klebsiella pneumoniae infection Child Death Risk factor
  • 相关文献

参考文献11

二级参考文献78

  • 1吴昊.铜陵地区产ESBLs大肠埃希菌、肺炎克雷伯菌的检测及耐药性分析[J].安徽医学,2005,26(5):358-360. 被引量:3
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 3Lepainteur M,Royer G,Bourrel AS,et al.Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative Staphylococci from very preterm neonates in NICU:the creeping threat[J].J Hosp Infect,2013,83(4):333-336.
  • 4Ceballos K,Waterman K,Hulett T,et al.Nurse-driven quality improvement interventions to reduce hospital-acquired infection in the NICU[J].Adv Neonatal Care,2013,13(3):154-163.
  • 5Morioka I,Yahata M,Shibata A,et al.Impact of pre-emptive contact precautions for outborn neonates on the incidence of healthcare-associated meticillin-resistant Staphylococcus aureus transmission in a Japanese neonatal intensive care unit[J].J Hosp Infect,2013,84(1):66-70.
  • 6Bennett NJ,Tabarani CM,Bartholoma NM,et al.Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization:aprospective surveillance study in two neonatal intensive care units[J].J Pediatr,2012,161(5):814-818.
  • 7Scheithauer S,Oude-Aost J,Heimann K,et al.Hand hygiene in pediatric and neonatal intensive care unit patients:daily opportunities and indication and profession-specific analyses of compliance[J].Am J Infect Control,2011,39(9):732-737.
  • 8Schulman J,Wirtschafter DD,Kurtin P.Neonatal intensive care unit collaboration to decrease hospital-acquired bloodstream infections:from comparative performance reports to improvement networks[J].Pediatr Clin North Am,2009,56(4):865-892.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty- fourth informational supplements, M100-$24[S]. Wayne, PA: CLSI, 2014.
  • 10Oteo J, Delgado-Iribarren A, Vega D, et al. Emergence of imipenem resistance in clin!ca!Escherichia coli during therapy[J], lnt JAntimicrob Agents, 2008, 32(6): 534-537.

共引文献272

同被引文献8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部